Jia Tang

Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC)

Richard A. Ward, Mark J. Anderton, Paul A. Bethel et al. · Journal of Medicinal Chemistry · 2019 · 78 citations · Full text

Medicine, Oncology, Pharmacology +17

Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start Point

Richard A. Ward, Paul A. Bethel, Calum Cook et al. · Journal of Medicinal Chemistry · 2017 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +16

<scp>IMM</scp>‐H004 prevents toxicity induced by delayed treatment of t<scp>PA</scp> in a rat model of focal cerebral ischemia involving <scp>PKA</scp>‐and <scp>PI</scp>3<scp>K</scp>‐dependent <scp>A</scp>kt activation

Wei Zuo, Jiao Chen, Shuai Zhang et al. · European Journal of Neuroscience · 2014 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +17

Piperine prevents cholesterol gallstones formation in mice

Xiu‐Yun Song, Shuang Xu, Jin‐Feng Hu et al. · European Journal of Pharmacology · 2015 · 36 citations

Medicine, Pharmacology, Pharmacotherapy +11

Preparation and neutralization efficacy of IgY antibodies raised against Deinagkistrodon acutus venom

Jinhua Liu, Qiyi He, Wenwen Wang et al. · ˜The œJournal of venomous animals and toxins including tropical diseases · 2017 · 31 citations · Full text

Pharmacy, Animal Sciences, Immunology +17